SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (2561)7/15/2001 4:52:27 PM
From: quidditchRead Replies (1) of 4974
 
$300 million, aggregate, between the company and "selling stockholder"?

Based on the <snips>, my guess is that the $300mm is in addition to the shares being offered by the selling stockholder.

Does anyone understand the rationale of/for the joint shelf registration?

Rick, the shelf registration under the S-3 appears to be part of the deal PSV made with VPHM at the time of the original investment in May 1999--VPHM pays for the registration and all related expenses. The shelf affords VPHM and PSV the ability to sell shares, or not to sell shares, at any time the company or PSV wants during the life of the shelf (evergreen until all VPHM shares registered ARE in fact sold), which allows PSV to pick its timing and bide its time, always with the liquidity of shares that are registered.

quid
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News